In one five-year period, college athletes suffered more than 10,000 concussions — one-third of them while playing football. But an unusual team-up has recently brought a new, biomarker-based concussion test one step closer.
Read/listen to my full story at KJZZ’s Arizona Science Desk:
TGen, ASU And Riddell Team Up To Create New Concussion Test
Mammals might seem like better human stand-ins than a minnow’s striped cousin, but zebrafish resemble us in surprising and useful ways. But zebrafish also offer practical advantages over other model species: They’re cheap, hardy, breed like rabbits on Viagra, and their skin can be made transparent.
To find out more about how Arizona researchers are using zebrafish in their research, read/listen to my full story at KJZZ’s Arizona Science Desk:
Tiny Fish Makes A Big Splash In Arizona Medical Research
New findings by the Translational Genomics Research Institute, or TGen, point to a surprising pattern in the brain cancer glioblastoma multiforme (GBM), the most common and deadly type of gliomas.
GBMs are aggressive, invasive and so genetically and structurally complex that advanced, targeted therapies have struggled to find vulnerabilities to attack.
Read/listen to my full story at KJZZ’s Arizona Science Desk:
TGen Brain Cancer Study Finds Surprising Benefit In Tumor Complexity
Scientists have identified drug targets that could one day make pancreatic cancer less painful — and more survivable — by knocking out key molecular signals. The signals form an essential part of the process by which cancer cells invade and spread through nearby nerves, wounding nerve endings.
Read/listen to my full story at KJZZ’s Arizona Science Desk:
New Drug Targets Could Reduce Pancreatic Cancer Pain, Improve Outcomes
